Wrap Technologies WRAP Unamortized Domestic Research And Development Costs

Unamortized Domestic Research And Development Costs at other companies

VirnetX Holding Corp VHC

$0-100%

BTCSBTCS

$122.52K-26.2%

ESABESAB

$22.04M+7.2%

IBT

IbottaIBTA

$22.65M-42.0%

Opko HealthOPK

$195M0.0%

Mineralys Therapeutics, Inc.MLYS

$39.94M-11.2%

Other financials

Income statement

See full

Revenue$1.1M+45.2%

Gross profit$691.0K+16.1%

Operating income-$4.8M-21.6%

Net income-$4.5M-4,265%

EPS (diluted)-$0.09—

Balance sheet

See full

Cash & equivalents$7.3M+17.7%

Total debt$459.0K-78.4%

Total equity$14.4M+462%

Total assets$16.7M-7.0%

Cash flow

See full

Operating cash flow-$1.2M+59.4%

CapEx$5.0K+150%

Free cash flow-$1.3M+59.3%

Valuation

See full

Market cap$71.9M-5.9%

Enterprise value$65.1M-12.3%

P/S14.3×-9.3×

Profitability

See full

Gross margin55.7%-2.9pp

Operating margin-285.6%-64.9pp

Net margin-298.6%+3,778pp

FCF margin-170.8%-24.7pp

Returns & leverage

See full

Return on equity-176.3%+10.5pp

Debt / equity0×-0.8×

Current ratio7.6×+6.6×

Where this comes from

Reported directly by Wrap Technologies in its filing.

Tagged under the XBRL concept wrap:UnamortizedDomesticResearchAndDevelopmentCosts.

The official record: Wrap Technologies’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wrap Technologies's unamortized domestic research and development costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Wrap Technologies's unamortized domestic research and development costs?: Wrap Technologies (WRAP) reported unamortized domestic research and development costs of $4.8M in Q4 2025.
What does unamortized domestic research and development costs mean?: The portion of domestic research and development expenditures that has been capitalized as an asset rather than expensed immediately. This represents the book value of ongoing innovation projects expected to provide future economic benefits. It serves as a proxy for the company's commitment to long-term product development and technological advancement.